Antioxidative Stress and Anti-Inflammatory Activity of Fucoidan Nanoparticles against Nephropathy of Streptozotocin-Induced Diabetes in Rats

Table 1

Effect of fucoidan nanoparticle on MDA levels of kidney tissues of streptozotocin-induced diabetic rat.

Group	Means ± SD
	MDA (nmol/mg)
Control group	2.24^a ± 0.28
Streptozotocin group	6.09^b ± 0.46
Fucoidan nano, 75 mg/kg BW	5.78^b ± 0.65
Fucoidan nano, 150 mg/kg BW	4.61^bc ± 0.53
Fucoidan nano, 300 mg/kg BW	3.82^cd ± 0.39

The different superscripts in each column show significant difference between the means ().